| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -1.14% | 27.39% | 88.51% | 115/139 | 1.16% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | -9.92% | 14.04% | -85.42% | 119/139 | 2.07% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | -5.35% | 10.39% | -15.3% | 123/139 | 0.51% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | -4.64% | -24.06% | -195.54% | 125/139 | 1.91% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | -1.57% | 10.8% | 86.4% | 120/139 | 1.04% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | -11.54% | -65.57% | -93.3% | 123/139 | 3.02% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | -5.97% | -194.09% | -59.63% | 122/139 | 4.75% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | -3.74% | -211.67% | -112.5% | 124/139 | 2.98% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | -1.76% | -865.22% | 74.75% | 119/139 | 1.65% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | -6.97% | -137.61% | -243.35% | 120/139 | 4.92% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | -2.03% | -109.18% | -69.17% | 114/139 | 5.8% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | -1.2% | -107.5% | -621.74% | 117/139 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 0.23% | -97.12% | -98.76% | 104/139 | 2.28% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 18.53% | -20.98% | -16.19% | 28/139 | 12.93% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 22.11% | 2% | 38.1% | 19/139 | 12.7% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 16.01% | 2% | -31.73% | 17/139 | 9.24% | 九安医疗 | 142.25% | 行业排名> |
| 2021-12-31 | 23.45% | -48.05% | 193.49% | 31/139 | 17.28% | 九安医疗 | 142.71% | 行业排名> |
| 2021-03-31 | 7.99% | 2% | -82.3% | 16/139 | 6.18% | 热景生物 | 121.78% | 行业排名> |
| 2020-12-31 | 45.14% | 171.11% | 171.11% | 21/139 | 25.47% | 热景生物 | 99.69% | 行业排名> |
| 2019-12-31 | 16.65% | 68.35% | 68.35% | 51/139 | 14.24% | 热景生物 | 99.09% | 行业排名> |
| 2018-12-31 | 9.89% | 2% | 2% | 73/139 | 12.87% | 热景生物 | 57.63% | 行业排名> |

微信公众号
证券之星APP


